Objective: To assess the utility of glycated albumin (GA%) as a diagnostic marker of type 2 diabetes and prediabetes in an African population.
Methods: GA% levels were determined in a sample of 1294 mixed ancestry adults (74.2% women) residing in Cape Town using an enzymatic method. The participants' glycemic status was based on oral glucose tolerance test (OGTT).
Results: The mean age was 47.8 years with a mean body mass index (BMI) of 28.7 kg/m. Obesity was more pronounced in the screen-detected diabetes and prediabetes groups with mean BMI's of 32.5 kg/m and 31.5 kg/m respectively. The optimal thresholds of GA% to diagnose screen-detected diabetes and prediabetes, were 14.90% and 12.75% respectively. For screen-detected diabetes, the C-statistic was higher for HbA1c than GA% (p = .034) with values of 0.899 (95% CI 0.855-0.943) and 0.873 (0.782-0.892) respectively. The agreement between GA% and HbA1c at their optimal thresholds for diagnosing screen-detected diabetes, was kappa = 0.33 (95% CI 0.26-0.40) and was higher than the agreement for prediabetes, kappa = 0.16 (0.11-0.21). The performance of GA% to identify screen-detected diabetes at the optimal threshold of 14.90%, was 64.8% (95% CI 54.1%-74.6%) for sensitivity and 93.5% (92.0%-94.9%) for specificity. GA% was significantly less sensitive, but more specific than HbA1c (at the optimal threshold of 6.15%) for screen-detected diabetes diagnosis (both p ≤ .002 from McNemar tests for sensitivity and specificity comparisons).
Conclusions: GA% performed less well than HbA1c to identify participants with OGTT-diagnosed type 2 diabetes or prediabetes (HbA1c cut-off of 6.15% and 5.95% respectively) in this population.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cca.2018.11.005 | DOI Listing |
Public Health Pract (Oxf)
June 2025
UI Health/University of Illinois Chicago College of Medicine, Department of Emergency Medicine Chicago, Illinois, USA.
Background: Screening for diabetes in non-traditional settings like emergency departments (ED) can enhance early detection among patients at higher risk for diabetes. This study aims to assess the reach of an ED-based screening program by examining the characteristics of patients screen-detected for diabetes or prediabetes.
Study Design: Retrospective cross-sectional study.
Eur J Public Health
December 2024
Department of General Practice, University of Turku and Southwest Finland Wellbeing Services County, Turku, Finland.
BMC Endocr Disord
October 2024
Centre of Excellence for Nutrition, Faculty of Health Sciences, North-West University, Potchefstroom Campus Private Bag X6001, Potchefstroom, 2520, South Africa.
Background: The use of non-invasive risk scores to detect undiagnosed type 2 diabetes (T2D) ensures the restriction of invasive and costly blood tests to those most likely to be diagnosed with the disease. This study assessed and compared the performance of the African Diabetes Risk Score (ADRS) with three other diabetes risk prediction models for identifying screen-detected diabetes based on fasting plasma glucose (FPG) or glycated haemoglobin (HBA1c).
Methods: Age, sex, waist circumference, body mass index, blood pressure, history of diabetes and physical activity levels from the SA-NW-PURE study were used to externally validate the ADRS and other established risk prediction models.
BMJ Open Diabetes Res Care
September 2024
Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Introduction: We describe the identification and management of general population screen-detected type 1 diabetes (T1D) and share learnings for best practice.
Research Design And Methods: Children diagnosed with T1D through a general population screening initiative, the EarLy Surveillance for Autoimmune diabetes (ELSA) study, were reviewed and described.Parents provided written, informed consent for inclusion in the case series.
Prim Care Diabetes
October 2024
Department of General Practice, University of Turku and Turku University Hospital, Turku, Finland.
Aims: To compare 13-year mortality rates in normoglycemic, prediabetic and diabetic subjects attending a community-based screening and intervention programme.
Methods: Population survey identified 2569 cardiovascular disease (CVD) white risk subjects aged 45-70 years and without manifested CVD or diabetes. Oral glucose tolerance test was performed, and multifactorial intervention was provided.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!